Prevalence and Diversity of Constitutional Mutations in the p53 Gene among 21 Li-Fraumeni Families

Cancer Research

Volumn 54, Issue 5, 1994, Pages 1298-1304

  Thompson, Eileen ^h   Mann, Jillian R ^h   Martin, John ^h   Kelsey, Anna M ^d   Harris, Martin ^d   Morris Jones, Patricia H ^e   Crowther, Derek ^d   Craft, Alan W ^f   Eden, Osborne B ^g  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b CRC Paediatric & Familial Cancer Research Group ^*  (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d Department of Histopathology ^*  (United Kingdom)

^e Pediatric Oncology   (United Kingdom)

^f ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^g ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^h BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADOLESCENT; ADULT; ARTICLE; BREAST CANCER; CHILD; CLINICAL ARTICLE; DELETION MUTANT; FAMILIAL CANCER; FEMALE; GENE INSERTION; GENE MUTATION; GENETIC POLYMORPHISM; GERM LINE; HUMAN; HUMAN TISSUE; MALE; MUTATION RATE; PEDIGREE; POINT MUTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SOFT TISSUE SARCOMA;

BASE SEQUENCE; CHILD; CODON; EXONS; FAMILY HEALTH; FEMALE; GENES, P53; HUMANS; LI-FRAUMENI SYNDROME; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PEDIGREE; PREVALENCE;

EID: 0028220688     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Li, F.P., and Fraumeni, J.F., Jr. Soft tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann. Intern. Med., 71: 747-752, 1969.
2. Birch, J.M., Hartley, A.L., Marsden, H.B., Harris, M., and Swindell, R. Excess risk of breast cancer in the mothers of children with soft tissue sarcomas. Br. J. Cancer, 45: 325-331, 1984.
3. Birch, J.M., Hartley, A.L., Blair, V., Kelsey, A.M., Harris, M., Teare, M.D., and Morris Jones, P.H. Cancer in the families of children with soft tissue sarcoma. Cancer (Phila.), 66: 2239-2248, 1990.
4. Hartley, A.L., Birch, J.M., Marsden, H.B., and Harris, M. Breast cancer risk in mothers of children with osteosarcoma and chondrosarcoma. Br. J. Cancer, 54: 819-823, 1986.
5. Strong, L.C., Stine, M., and Norsted, T.L. Cancer in survivors of childhood soft tissue sarcoma and their relatives. J. Natl. Cancer Inst., 79: 1213-1220, 1987.
6. Li, F.P., Fraumeni, J.F., Jr., Mulvihill, J.J., Blattner, W.A., Dreyfus, M.G., Tucker, M.A., and Miller, R.W. A cancer family syndrome in twenty-four kindreds. Cancer Res., 48: 5358-5362, 1988.
7. Garber, J.E., Goldstein, A.M., Kantor, A.F., Dreyfus, M.G., Fraumeni, J.F., Jr., and Li, F.P. Follow up study of twenty-four families with Li-Fraumeni syndrome. Cancer Res., 51: 6094-6097, 1991.
8. Malkin, D., Li, F.P., Strong, L.C., Fraumeni, J.F., Jr., Nelson, C.E., Kim, D.H., Kassel, J., Gryka, M.A., Bischoff, F.Z., Tainsky, M.A., and Friend, S.H. Germline p. 3 mutations in a familial syndrome of breast cancer, sarcoma, and other neoplasms. Science (Washington DC), 250: 1233-1238, 1990.
9. Srivastava, S., Zou, Z., Pirollo, K., Blattner, W., and Chang, E.H. Germline transmission of a mutated p. 3 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature (Lond.), 348: 147-749, 1990.
10. Levine, A.J. Momand, J., and Finlay, C.A. The p. 3 tumour suppressor gene. Nature (Lond.), 351: 453-456, 1991.
11. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C.C.p. 3 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
12. Santibanez-Koref, M.F., Birch, J.M., Hartley, A.L., Morris Jones, P.H., Craft, A.W., Eden, T., Crowther, D., Kelsey, A.M., and Harris, M. p. 3 germline mutations in Li-Fraumeni syndrome. Lancet, 338: 1490-1491, 1991.
13. Law, J.C., Strong, L.C., Chidambaram, A., and Ferrell, R.E. A germline mutation in exon 5 of the p. 3 gene in an extended cancer family. Cancer Res., 51: 6384-6387, 1991.
14. Metzger, A.K., Sheffield, V.C., Duyk, G., Daneshvar, L., Edwards, M.S.B., and Cogen, P.H. Identification of a germline mutation in the p. 3 gene in a patient with an intracranial ependymoma. Proc. Natl. Acad. Sci. USA, 88: 7825-7829, 1991.
15. Sameshima, Y., Tsunematsu, Y., Watanabe, S., Tsukamoto, T., Kawa-Ha, K., Hirata, Y., Mizoguchi, H., Sugimura, T., Terada, M., and Yokota, J. Detection of novel germline p. 3 mutations in diverse cancer-prone families identified by selecting patients with childhood adrenocortical carcinoma. J. Natl. Cancer Inst., 84: 703-707, 1992.
16. Kovar, H., Auinger, A., Jug, G., Muller, T., and Pillwein, K. p. 3 mosaicism with an exon 8 germline mutation in the founder of a cancer-prone pedigree. Oncogene, 7: 2169-2173, 1992.
17. Eeles, R.A., Warren, W., Knee, G., Bartek, J., Averill, D., Stratton, M.R., Blake, P.R., Tait, D.M., Lane, D.P., Easton, D.F., Yarnold, J.R., Cooper, C.S., and Sloane, J.P. Constitutional mutation in exon 8 of the p. 3 gene in a patient with multiple primary tumours: molecular and immunohistochemical analysis. Oncogene, 8: 1269-1276, 1993.
18. Toguchida, J., Yamaguchi, T., Ritchie, B., Beauchamp, R.L., Dayton, S.H., Herrera, G.E., Yamamuro, T., Motoura, Y., Sasaki, M.S., Little, J.B., Weichselbaum, R.R., Ishizaki, K., and Yandell, D.W. Mutation spectrum of the p. 3 gene in bone and soft tissue sarcomas. Cancer Res., 52: 6194-6199, 1992.
19. Brugieres, L., Gardes, M., Moutou, C., Chompret, A., Meresse, V., Martin, A., Poisson, M., Flamant, F., Bonaiti-Pellie, C., Lemerle, J., and Feunteun, J. Screening for germline p. 3 mutations in children with malignant tumors and a family history of cancer. Cancer Res., 53: 452-455, 1993.
20. Iavarone, A., Matthay, K.K., Steinkirchner, T.M., and Israel, M.A. Germline and somatic p. 3 gene mutations in multifocal osteogenic sarcoma. Proc. Natl. Acad. Sci. USA, 89: 4207-4209, 1992.
21. Malkin, D., Jolly, K.W., Barbier, N., Look, A.T., Friend, S.H., Gebhardt, M.C., Andersen, T.I., Borresen, A.L., Li, F.P., Garber, J., and Strong, L.C. Germline mutations of the p. 3 tumor-suppressor gene in children and young adults with second malignant neoplasms. N. Engl. J. Med., 326: 1309-1315, 1992.
22. Felix, C.A., Strauss, E.A., D'Amico, D., Tsokos, M., Winter, S., Mitsudomi, T., Nau, M.M., Brown, D.L., Leahey, A.M., Horowitz, M.E., Poplack, D.G., Costin, D., and Minna, J.D. A novel germline p. 3 splicing mutation in a pediatric patient with a second malignant neoplasm. Oncogene, 8: 1203-1210, 1993.
23. Felix, C.A., Chavez Kappel, C., Mitsudomi, T., Nau, M.M., Tsokos, M., Crouch, G.D., Nisen, P.D., Winick, N.J., and Helman, L.J. Frequency and diversity of p. 3 mutations in childhood rhabdomyosarcoma. Cancer Res., 52: 2243-2247, 1992.
24. Sidransky, D., Tokino, T., Helzlsouer, K., Zehnbauer, B., Rausch, G., Shelton, B., Prestigiacomo, L., Vogelstein, B., and Davidson, M. Inherited p. 3 gene mutations in breast cancer. Cancer Res., 52: 2984-2986, 1992.
25. Borresen, A.L., Andersen, T.I., Garber, J., Barbier-Piraux, N., Thorlacius, S., Eyfjord, J., Ottestad, L., Smith-Sorensen, B., Hovig, E., Malkin, D., and Friend, S.H. Screening for germline TP53 mutations in breast cancer patients. Cancer Res., 52: 3234-3236, 1992.
26. Coles, C., Condie, A., Chetty, U., Steel, C.M., Evans, H.J., and Prosser, J. p. 3 mutations in breast cancer. Cancer Res., 52: 5291-5298, 1992.
27. Sambrook, J., Fritsch, E.F., and Maniatis, T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
28. Wright, D.K., and Manos, M. In: M.A. Innis, D.H. Gelfond, J.J. Snisky, and T.J. White (eds.), PCR Protocols, pp. 153-158. San Diego: Academic Press, 1990.
29. Hsu, I.C., Metcalf, R.A., Sun, T., Welsh, J.A., Wang, N.J., and Harris, C.C. Mutational hotspot in the p. 3 gene in human hepatocellular carcinomas. Nature (Lond.), 350: 427-428, 1991.
30. Hultman, T., Stahl, S., Homes, E., and Uhlen, M. Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support. Nucleic Acids Res., 17: 4937, 1989.
31. Cotton, R.G.H., Rodrigues, N.R., and Campbell, R.D. Reactivity of cytosine and thymine in single-base-pair mismatches with hydroxylamine and osmium tetroxide and its application to the study of mutations. Proc. Natl. Acad. Sci. USA, 85: 4397-4401, 1988.
32. Lazar, V., Hazard, F., Berlin, F., Janin, N., Bellet, D., and Bressac, B. Simple sequence polymorphism within the p. 3 gene. Oncogene, 8: 1703-1705, 1993.
33. de la Calle-Martin, O., Fabregat, V., Romero, M., Soler, J., Vives, J., and Yague, J. AcII polymorphism of the p. 3 gene. Nucleic Acids Res., 18: 4963, 1990.
34. Caron de Fromental, C., and Soussi, T. The TP53 tumor suppressor gene: a model for investigating human mutagenesis. Genes Chromosomes Cancer, 4: 1-15, 1992.
35. Vogelstein, B. A deadly inheritance. Nature (Lond.), 348: 681-682, 1990.
36. Dittmer, D., Pati, S., Zambetti, G., Chu, S., Teresky, A.K., Moore, M., Finlay, C., and Levine, A.J. Gain of function mutations in p. 3. Nature Genet., 4: 42-46, 1993.
37. Frebourg, T., Kassel, J., Lam, K.T., Gryka, M.A., Barbier, N., Anderson, T.I., Borresen, A.L., and Friend, S.H. Germline mutations of the p. 3 tumor suppressor gene in patients with high risk for cancer inactivate the p. 3 protein. Proc. Natl. Acad. Sci. USA, 89: 6413-6417, 1992.
38. Birch, J.M. Germline mutations in the p. 3 tumour suppressor gene: scientific, clinical and ethical challenges. Br. J. Cancer, 66: 424-426, 1992.
39. Li, F.P., Garber, J.E., Friend, S.H., Strong, L.C., Patenaude, A.F., Juengst, E.T., Reilly, P.R., Correa, P., and Fraumeni, J.F., Jr. Recommendations on predictive testing for germline p. 3 mutations in cancer-prone individuals. J. Natl. Cancer Inst., 84: 1156-1160, 1992.
40. Lustbader, E.D., Williams, W.R., Bondy, M.L., Strom, S., and Strong, L.C. Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients. Am. J. Hum. Genet., 51: 344-356, 1992.
41. Lane, D.P. A death in the life of p. 3. Nature (Lond.), 362: 786-787, 1993.